Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

11 trials with published results (21%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.8%

2 terminated out of 53 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

17%

9 trials in Phase 3/4

Results Transparency

37%

11 of 30 completed with results

Key Signals

11 with results94% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (13)
P 1 (4)
P 2 (4)
P 3 (8)
P 4 (1)

Trial Status

Completed30
Recruiting9
Unknown6
Not Yet Recruiting3
Active Not Recruiting2
Terminated2

Trial Success Rate

93.8%

Benchmark: 86.6%

Based on 30 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT07852936Not ApplicableRecruiting

Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury: A Clinical Development and Evaluation Study

NCT06368648Recruiting

CoMind Early Feasibility Study

NCT07830927Not Yet RecruitingPrimary

Early Neurological Outcome in Pediatric Encephalitis

NCT05413733Not ApplicableCompleted

Neuropsychological Rehabilitation Over the Internet

NCT07432113Not ApplicableRecruiting

Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.

NCT05393492Not ApplicableRecruiting

Regulating Emotions and Behaviors After Brain Injury

NCT07241858Not Yet Recruiting

Clinicolaboratory Predictors of Outcome in Children With Encephalitis

NCT07200687Not ApplicableActive Not Recruiting

Effects of Combined Music Therapy and Occupational Therapy on Motor and Physiological Parameters in Children With Neurological Impairments: A Non-Randomized Controlled Trial

NCT06899802Phase 2Active Not RecruitingPrimary

A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine

NCT07186881Enrolling By Invitation

Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis

NCT06067750Completed

Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation

NCT04372615Phase 2Recruiting

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

NCT06584045Not ApplicableRecruitingPrimary

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

NCT04190303Completed

BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally

NCT06849011Not Yet Recruiting

Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients

NCT02979951Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT04080921Phase 1CompletedPrimary

Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis

NCT03418441Recruiting

Central Nervous System Infections in Denmark

NCT02906631CompletedPrimary

Epidemiology and Prognosis of Encephalitis in Intensive Care

NCT02308982Phase 3CompletedPrimary

Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis

Scroll to load more

Research Network

Activity Timeline